Real-time PCR or quantitative PCR is a well-established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of a fluorescent signal. Comparison to a reference sample determines the number of original copies of template DNA in the reaction.

Digital PCR is a highly precise approach to sensitive nucleic acid detection and quantification. Each sample is partitioned into thousands of individual reactions (droplets for Droplet Digital™ PCR technology). Each partition is analyzed after end-point PCR cycling for the presence or absence of a fluorescent signal, and the absolute number of molecules present in the sample is calculated. dPCR does not require a standard curve for quantification.

Both quantitative PCR (qPCR) and digital PCR (dPCR) provide sensitive and specific detection, and precise quantification of nucleic acids. Both technologies have similarities, but they have differences that make one or the other the more adapted choice for specific applications.
Global qPCR and dPCR Instrumentation key players include Thermo Fisher, Roche, QIAGEN, Bio-rad, etc. Global top four manufacturers hold a share over 70%.
North America is the largest market, with a share over 50%, followed by China and Europe, both have a share about 40 percent.
In terms of product, qPCR is the largest segment, with a share over 70%. And in terms of application, the largest application is Research Use, followed by Clinical Use, etc.

Market Analysis and Insights: Global qPCR and dPCR Instrumentation Market
In 2020, the global qPCR and dPCR Instrumentation market size was US$ 1158 million and it is expected to reach US$ 1895.5 million by the end of 2027, with a CAGR of 7.3% during 2021-2027.
Global qPCR and dPCR Instrumentation Scope and Market Size
qPCR and dPCR Instrumentation market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global qPCR and dPCR Instrumentation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.

Segment by Type, the qPCR and dPCR Instrumentation market is segmented into
dPCR
qPCR

Segment by Application, the qPCR and dPCR Instrumentation market is segmented into
Clinical Use
Research Use
Other

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape and qPCR and dPCR Instrumentation Market Share Analysis
qPCR and dPCR Instrumentation market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, qPCR and dPCR Instrumentation product introduction, recent developments, qPCR and dPCR Instrumentation sales by region, type, application and by sales channel.

The major companies include:
Thermo Fisher
Roche
QIAGEN
Bio-rad
Agilent
Bioer
Biosynex
Esco
Analytik Jena
Techne
Fluidigm
RainDance Technologies